Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-09-29 7:49 pm Purchase | 13G | Revolution Medicines, Inc. RVMD | BB BIOTECH AG | 4,602,562 5.2% | 4,602,562![]() (New Position) | View |
2022-08-30 5:02 pm Sale | 13D | Radius Health, Inc. RDUS | BB BIOTECH AG | 0 0% | -8,255,714![]() (Position Closed) | View |
2022-04-14 12:01 pm Purchase | 13G | Black Diamond Therapeutics, Inc. BDTX | BB BIOTECH AG | 3,988,402 11% | 548,402![]() (+15.94%) | View |
2022-02-11 4:57 pm Purchase | 13G | Black Diamond Therapeutics, Inc. BDTX | BB BIOTECH AG | 3,440,000 9.5% | 1,540,000![]() (+81.05%) | View |
2022-02-11 4:51 pm Purchase | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,312,292 7.9% | 153,390![]() (+3.69%) | View |
2022-02-11 4:49 pm Purchase | 13G | Molecular Templates, Inc. MTEM | BB BIOTECH AG | 10,792,003 19.2% | 1,249,382![]() (+13.09%) | View |
2022-02-11 4:48 pm Sale | 13G | Cidara Therapeutics, Inc. CDTX | BB BIOTECH AG | 0 0% | -2,822,495![]() (Position Closed) | View |
2022-02-11 4:47 pm Purchase | 13G | Myovant Sciences Ltd. MYOV | BB BIOTECH AG | 6,122,039 6.6% | 1,365,000![]() (+28.69%) | View |
2022-02-11 4:46 pm Purchase | 13G | ESSA Pharma Inc. EPIX | BB BIOTECH AG | 5,015,814 11.4% | 250,000![]() (+5.25%) | View |
2022-02-11 4:44 pm Purchase | 13G | Generation Bio Co. GBIO | BB BIOTECH AG | 3,853,180 6.8% | 1,460,000![]() (+61.01%) | View |
2022-02-11 4:42 pm Purchase | 13G | Wave Life Sciences Ltd. WVE | BB BIOTECH AG | 4,602,858 7.8% | 2,000,000![]() (+76.84%) | View |
2022-02-11 4:42 pm Purchase | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 10,232,973 7.2% | 2,012,973![]() (+24.49%) | View |
2022-02-11 4:41 pm Purchase | 13G | Kezar Life Sciences, Inc. KZR | BB BIOTECH AG | 4,918,148 9.2% | 385,000![]() (+8.49%) | View |
2022-02-11 4:39 pm Purchase | 13G | Scholar Rock Holding Corporation SRRK | BB BIOTECH AG | 2,275,125 6.5% | 19,474![]() (+0.86%) | View |
2022-02-11 4:39 pm Unchanged | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 4,477,964 7.1% | 0 (Unchanged) | View |
2022-02-11 4:38 pm Purchase | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 7,275,564 11.9% | 1,250,000![]() (+20.74%) | View |
2022-02-11 4:36 pm Purchase | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 3,170,104 5.4% | 210,000![]() (+7.09%) | View |
2022-02-11 4:34 pm Sale | 13G | Voyager Therapeutics, Inc. VYGR | BB BIOTECH AG | 0 0% | -2,680,283![]() (Position Closed) | View |
2022-01-18 09:29 am Purchase | 13D | Radius Health, Inc. RDUS | BB BIOTECH AG | 8,255,714 17.4% | 800,000![]() (+10.73%) | View |
2021-09-15 6:23 pm Purchase | 13G | Mersana Therapeutics, Inc. MRSN | BB BIOTECH AG | 4,135,000 5.8% | 4,135,000![]() (New Position) | View |